Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. - Toft-Nielsen,MB.; Madsbad,S.; Holst,JJ. (Diabetes Care, 1999)